Relationship of vascular risk to the progression of Alzheimer disease
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To test the hypothesis that patients with Alzheimer disease (AD) who have vascular risk factors have a worse prognosis over 18 months vs those without such risk factors. METHODS: A sample of 224 people with AD and their caregivers were recruited purposively to be representative of people with dementia in terms of cognition, sex, and living situations in a longitudinal study of AD. Standardized instruments measuring cognition, functional status, and neuropsychiatric symptoms were used to collect data. Physical examination and relevant blood tests were performed. RESULT: There was no difference in rate of deterioration between people with and without vascular risk factors, except in those who had a cerebrovascular accident (CVA) during the 18-month follow-up (p < 0.001). We considered possible confounders of outcome: sex, age, years of education, severity of dementia, depression, taking cholinesterase inhibitors (AChEIs), and whether those with vascular risk factors were more likely to die, but the results remained unchanged. Stopping AChEIs during the study was associated with cognitive and functional decline (p < 0.001). CONCLUSIONS: Vascular risk factors as measured clinically and biochemically do not significantly increase deterioration at 18 months in people with Alzheimer disease who have a low burden of cerebrovascular risk factors. However, cerebrovascular events are associated with more rapid decline. Vascular risk factors may contribute to the expression of Alzheimer disease initially but are not part of the underlying etiologic process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Midlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238
Research works printed but not linked: 27
- 10.1097/00002093-199912003-00017 · DOI · Paper page
- 10.1097/00041433-200404000-00005 · DOI
- Breteler MM, Bots ML, Ott A, Hofman A. Risk factors for vascular disease and dementia. Haemostasis 1998;28:167–173.
- 10.1016/S0140-6736(96)09328-2 · DOI · Paper page
- 10.1192/bjp.177.1.66 · DOI · Paper page
- 10.1136/bmj.38446.466238.E0 · DOI · Paper page
- Bugiani O. AB-related cerebral amyloid angiopathy. Neurol Sci 2004;24:S1–S2.
- 10.1212/WNL.58.10.1471 · DOI · Paper page
- 10.1073/pnas.94.11.5923 · DOI · Paper page
- 10.1212/01.WNL.0000158476.74580.A8 · DOI
- 10.1016/0021-9681(74)90013-7 · DOI · Paper page
- Regan C, Katona C, Walker Z, Livingston G. Relationship of exercise and other risk factors to depression of Alzheimer’s disease: the LASER-AD study. Int J Geriatr Psychiatry 2005;20:261–268.
- Fratglioni L. Health economics of dementia. Epidemiology 1998;2:13–31.
- 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders fourth edition.Washington DC: American Psychiatric Association 1994;138–142.
- 10.1212/WNL.34.7.939 · DOI · Paper page
- 10.2337/diacare.25.2.275 · DOI · Paper page
- 10.1037/1040-3590.2.3.298 · doi:10.1037/1040-3590.2.3.298 · Paper page
- Mohs RC, Rosen WG, Davis KL. The Alzheimer’s Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19:448–450.
- Mohs RC, Cohen L. Alzheimer’s Disease Assessment Scale (ADAS). Psychopharmacol Bull 1988;24:627–628.
- 10.1097/00002093-199700112-00005 · DOI · Paper page
- 10.1093/ageing/32.2.200 · DOI · Paper page
- 10.1056/NEJM199301213280301 · DOI · Paper page
- 10.1093/oxfordjournals.aje.a116417 · DOI · Paper page
- 10.1136/jnnp.65.2.143 · DOI · Paper page
- 10.1136/jnnp.2003.030189 · DOI · Paper page
- 10.1159/000026149 · DOI · Paper page
Cited by
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643
“In elderly AD patients, CVD leads to more rapid cognitive deterioration (83, 84).”
BackgroundVascular comorbidity is associated with more rapid disability progression in multiple sclerosis
Marrie, R. A., Rudick, R., Horwitz, R., Cutter, G., Tyry, T., Campagnolo, D., & Vollmer, T. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6b125 · Cited by 479
Long-term PM 2.5 Exposure and Neurological HospitalAdmissions in the Northeastern United States
Kioumourtzoglou, M.-A., Schwartz, J. D., Weisskopf, M. G., Melly, S. J., Wang, Y., Dominici, F., & Zanobetti, A. (2016) · Environmental Health Perspectives · doi:10.1289/ehp.1408973 · Cited by 466
Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365
Pathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353
“…with neocortical more than entorhinal and hippocampal atrophy (Du et al., 2002), that are more severe in AD than in VaD (Zarow et al., 2005), and increase the risk of dementia, particularly in patients with lacunar infarcts (Wen et al., 2004; Regan et al., 2006) and SVaD (van de Pol et al., 2011).”
Background
Metadata
- Authors
- Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J., & Livingston, G.
- Venue
- Neurology
- Published
- 2006-10-24
- Volume
- 67
- Issue
- 8
- Pages
- 1357-1362
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2107917334
- Cited by
- 126
- References
- 13
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relationship of vascular risk to the progression of Alzheimer disease. https://app.cochat.ai/papers/10.1212/01.wnl.0000240129.46080.53
- The paper
- Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J., & Livingston, G. (2006). Relationship of vascular risk to the progression of Alzheimer disease. Neurology. https://doi.org/10.1212/01.wnl.0000240129.46080.53
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.